Periscope Capital’s Avista Healthcare Public Acquisition Corp. Warrants AHPAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-364,500
Closed -$69K 220
2018
Q3
$69K Sell
364,500
-200,000
-35% -$57.8K 0.01% 151
2018
Q2
$262K Sell
564,500
-600
-0.1% -$210 0.06% 122
2018
Q1
$187K Sell
565,100
-273,300
-33% -$104K 0.04% 108
2017
Q4
$234K Buy
838,400
+424,700
+103% +$150K 0.06% 95
2017
Q3
$166K Buy
413,700
+171,300
+71% +$71.9K 0.06% 79
2017
Q2
$109K Buy
242,400
+142,400
+142% +$62.3K 0.04% 68
2017
Q1
$50K Buy
+100,000
New +$49K 0.02% 55

Periscope Capital's AHPAW Position: Q4 2018 in Review

Periscope Capital sold out of Avista Healthcare Public Acquisition Corp. Warrants (AHPAW) in Q4 2018, closing a stake of 364,500 shares — an estimated $69K sold.

Periscope Capital first reported a position in AHPAW in Q1 2017 and held it in 7 quarters. The position peaked at $262K in Q2 2018. 0 funds tracked by Wall St. Rank hold AHPAW as of Q4 2018.

  • Periscope Capital reported no remaining Avista Healthcare Public Acquisition Corp. Warrants position as of Q4 2018 after selling out during the quarter.
  • Periscope Capital sold 364,500 Avista Healthcare Public Acquisition Corp. Warrants shares in Q4 2018, an estimated $69K.
  • Periscope Capital first reported a position in Avista Healthcare Public Acquisition Corp. Warrants in Q1 2017 and held it in 7 quarters.
  • Periscope Capital's Avista Healthcare Public Acquisition Corp. Warrants position peaked at $262K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Avista Healthcare Public Acquisition Corp. Warrants as of Q4 2018.

Based on Periscope Capital's 13F filing for Q4 2018, filed 13 Feb 2019.